Postpartum clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
Sorry, not yet accepting patients
This is a Phase I/II, multicenter, open-label, non-randomized study with four groups to characterize the pharmacokinetics and safety of Cabotegravir (CAB) and Rilpivirine (RPV) long-acting injectable (LA) during pregnancy and postpartum among people with HIV-1 viral suppression and their infants.
La Jolla, California and other locations
Last updated: